Хайлтын үр дүнгүүд - Francesco Passamonti

Үр дүнг сайжруулах
  1. 1
    How I treat polycythemia vera

    How I treat polycythemia vera -н Francesco Passamonti

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Clinical relevance of JAK2 (V617F) mutant allele burden

    Clinical relevance of JAK2 (V617F) mutant allele burden -н Francesco Passamonti, Elisa Rumi

    Хэвлэсэн 2009
    Бүрэн текст авах Бүрэн текст авах
    Carta
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Update from the latest WHO classification of MPNs: a user’s manual

    Update from the latest WHO classification of MPNs: a user’s manual -н Francesco Passamonti, Margherita Maffioli

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    The role of JAK2 inhibitors in MPNs 7 years after approval

    The role of JAK2 inhibitors in MPNs 7 years after approval -н Francesco Passamonti, Margherita Maffioli

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Myelofibrosis

    Myelofibrosis -н Francesco Passamonti, Barbara Mora

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia

    Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia -н Alessandro Squizzato, Erica Romualdi, Francesco Passamonti, Saskia Middeldorp

    Хэвлэсэн 2013
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies

    Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies -н Francesco Passamonti, Margherita Maffioli, Domenica Caramazza, Mario Cazzola

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis

    Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis -н Francesco Passamonti, Francisco Cervantes, Alessandro M. Vannucchi, Enrica Morra, Elisa Rumi, Mario Cazzola, Ayalew Tefferi

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Anemia in myelofibrosis: Current and emerging treatment options

    Anemia in myelofibrosis: Current and emerging treatment options -н Francesco Passamonti, Claire Harrison, Ruben A. Mesa, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, Srđan Verstovšek

    Хэвлэсэн 2022
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Transfusion‐dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis—prognostic relevance is independent of IPSS or karyotype

    Transfusion‐dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis—prognostic relevance is... -н Ayalew Tefferi, Sergio Siragusa, Kebede Hussein, Susan M. Schwager, Curtis A. Hanson, Animesh Pardanani, Francisco Cervantes, Francesco Passamonti

    Хэвлэсэн 2009
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

    Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis -н Nico Gagelmann, Francesco Passamonti, Christine Wolschke, Radwan Massoud, Christian Niederwieser, Raissa Adjallé, Barbara Mora, Francis Ayuk, Nicolaus Kröger

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    A Gain-of-Function Mutation of<i>JAK2</i>in Myeloproliferative Disorders

    A Gain-of-Function Mutation of<i>JAK2</i>in Myeloproliferative Disorders -н Róbert Královics, Francesco Passamonti, Andreas Buser, Soon-Siong Teo, Ralph Tiedt, Jakob Passweg, André Tichelli, Mario Cazzola, Radek C. Skoda

    Хэвлэсэн 2005
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS

    Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS -н Chiara Elena, Francesco Passamonti, Elisa Rumi, Luca Malcovati, Luca Arcaini, Emanuela Boveri, Michele Merli, Daniela Pietra, Cristiana Pascutto, Mario Lazzarino

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients

    Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients -н Elisa Rumi, Francesco Passamonti, Chiara Elena, Daniela Pietra, Luca Arcaini, C. Astori, Silvia Zibellini, Emanuela Boveri, C. Pascutto, Mario Lazzarino

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Long-term Events in Adult Patients with Clinical Stage IA-IIA Nonbulky Hodgkin's Lymphoma Treated with Four Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Adjuvant Radiotherapy: A Single-Institution 15-Year Follow-up

    Long-term Events in Adult Patients with Clinical Stage IA-IIA Nonbulky Hodgkin's Lymphoma Treated with Four Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Adjuv... -н Ercole Brusamolino, A. Baio, Ester Orlandi, Luca Arcaini, Francesco Passamonti, Vassiliki Griva, William Casagrande, Cristiana Pascutto, P. Franchini, Mario Lazzarino

    Хэвлэсэн 2006
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia

    Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia -н Guido Finazzi, Alessandra Carobbio, Paola Guglielmelli, Chiara Cavalloni, Silvia Salmoiraghi, Alessandro M. Vannucchi, Mario Cazzola, Francesco Passamonti, Alessandro Rambaldi, Tiziano Barbui

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinib

    Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinib -н Francesco Passamonti, Siddhi Korgaonkar, Rohan Parikh, Manoj Chevli, Aylin Yücel, Julien Rombi, Shalon Jones, Dieter Zissler, Keith L. Davis, Samantha Slaff

    Хэвлэсэн 2025
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms

    The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms -н Damla Olcaydu, Elisa Rumi, Ashot S. Harutyunyan, Francesco Passamonti, Daniela Pietra, Cristiana Pascutto, Tobias Berg, Roland Jäger, E. Hammond, M. Cazzola, Róbert Královics

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2

    Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2 -н Róbert Královics, Soon-Siong Teo, Andreas Buser, Martin Brutsche, Ralph Tiedt, André Tichelli, Francesco Passamonti, Daniela Pietra, Mario Cazzola, Radek C. Skoda

    Хэвлэсэн 2005
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Defining disease modification in myelofibrosis in the era of targeted therapy

    Defining disease modification in myelofibrosis in the era of targeted therapy -н Naveen Pemmaraju, Srđan Verstovšek, Ruben A. Mesa, Vikas Gupta, Jacqueline S. Garcia, Joseph M. Scandura, Stephen T. Oh, Francesco Passamonti, Konstanze Döhner, Adam J. Mead

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: